Deciphering NF-kappaB pathways in smoking-related lung carcinogenesis

Area of Science:

• Oncology
• Molecular Biology
• Public Health

Background:

• Lung cancer, a leading global cause of death, is strongly linked to cigarette smoking.
• The transcription factor NF-κB (nuclear factor kappa B) regulates inflammatory responses and cellular processes, and is implicated in cancer development.
• Cigarette smoke contains carcinogens that damage lung tissue and activate signaling pathways.

Purpose of the Study:

• To review the critical function of NF-κB in the molecular pathways of smoking-induced lung cancer.
• To elucidate the role of NF-κB activation in lung carcinogenesis.
• To identify potential therapeutic targets for lung cancer treatment.

Main Methods:

• Literature review of studies on NF-κB signaling in lung cancer.
• Analysis of molecular mechanisms linking cigarette smoke exposure to NF-κB activation.
• Examination of crosstalk between NF-κB and other signaling pathways (e.g., MAPK, PI3K-Akt).

Main Results:

• NF-κB activation is a pivotal event in the pathogenesis of smoking-induced lung cancer.
• Cigarette smoke components trigger NF-κB via oxidative stress and inflammatory cytokines.
• Crosstalk between NF-κB and pathways like MAPK and PI3K-Akt amplifies inflammation, promoting tumorigenesis.

Conclusions:

• NF-κB plays a critical role in the initiation and progression of lung cancer caused by smoking.
• Understanding NF-κB's involvement offers insights into the molecular basis of lung carcinogenesis.
• Targeting NF-κB signaling presents a potential therapeutic strategy for smoking-related lung cancer.